Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1924 News Items found FDA Approves Lirafugratinib for Treating Cholangiocarcinoma Caused by FGFR2 Mutations Thursday, October 1, 2026 The FDA has approved lirafugratinib for patients with advanced cholangiocarcinoma that carries an FGFR2 fusion or rearrangement, giving them a new option for targeted therapy. Ask the Expert Five Myths About the Flu Shot Thursday, October 1, 2026 MSK infectious disease specialist Monika Shah debunks common myths about the flu shot. How Genetic Cascade Testing Can Break the Cycle of Inherited Cancer Risk Thursday, October 1, 2026 Learn how the diagnosis of an inherited BRCA1 mutation is helping one family reduce its cancer risk. Q&A What People With Cancer Should Know About the 2026–27 Flu Season Thursday, October 1, 2026 Learn why it's important to get a flu shot this year. What To Know About the RSV Vaccines: Who Can Get Them, Side Effects, and Availability at MSK Thursday, October 1, 2026 RSV is a respiratory disease that spreads in the fall and winter months. Learn about the RSV vaccines. People ages 18 to 74 who are at risk for getting very sick from RSV should get vaccinated. Everyone ages 75 and older should get an RSV vaccine. Feature Skin Cancer on the Face: Five Things To Know After a Diagnosis Wednesday, September 30, 2026 Dermatologic surgeon Dr. Erica Lee offers expert advice to people with skin cancer on their nose, eyelid, or another area of their face. Stay Up to Date on Flu, RSV, and COVID-19 Vaccines Wednesday, September 30, 2026 Flu, RSV, and COVID-19 vaccines are especially important for people with cancer. Learn which vaccines to ask about and how to get them at MSK. Study Suggests Sugar Can Worsen Common Intestinal Side Effect of Antibiotics Wednesday, September 30, 2026 A new study found that consuming high levels of sugar while taking antibiotics appears to worsen common gastrointestional side effects in patients receiving bone marrow transplants. What Is Invasive Lobular Carcinoma? MSK Doctors Explain Wednesday, September 30, 2026 Learn how MSK’s Lobular Breast Cancer Program is working to improve outcomes for people with invasive lobular breast cancer and other types of LBC, as well as the latest treatment and research. Q&A What To Know About Pancreatic Cancer Tuesday, September 29, 2026 Learn about important advances in the treatment of pancreatic cancer. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment